Latest news
AstraZeneca PLC Stock 12‑Month Price Target Raised to GBX 16091.9, Implies 36% Upside - TradingViewTradingView · Fri, 07 Aug 2026 04:20:00 GMT'No discussions' over AstraZeneca-Bristol Myers deal, senior source says - TradingViewTradingView · Wed, 05 Aug 2026 13:50:32 GMTAstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks - TradingViewTradingView · Mon, 03 Aug 2026 20:29:41 GMTREG - AstraZeneca PLC - Admission of Further Securities to Trading - TradingViewTradingView · Mon, 03 Aug 2026 14:05:00 GMTWeekly Recap: AstraZeneca merger talks and NYSE:BMY raises 2026 guidance - TradingViewTradingView · Mon, 03 Aug 2026 11:33:16 GMTAstraZeneca launches Imjudo cancer drug in China - TradingViewTradingView · Mon, 03 Aug 2026 10:13:38 GMTAstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal - TradingViewTradingView · Mon, 03 Aug 2026 07:16:33 GMTAstraZeneca shares seen slipping 3% after reported Bristol Myers talks - TradingViewTradingView · Mon, 03 Aug 2026 06:53:00 GMT